TOP STORIES
Theranos takes another punch: “A federal inspection report said a Theranos Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic results from quality-control checks meant to ensure the test’s accuracy.” – The Wall Street Journal
This has a long way to go, but it’s worth watching. Proposed federal legislation would provide a tax credit to family caregivers: working families could get an annual credit of up to 30 percent of caregiving expenses or $3,000, whichever is less. – The Hill
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Canon and Fujifilm are in the lead to take over Toshiba’s medical equipment unit. We’ll know more by end of day Wednesday. – Reuters
Get another CRISPR patent preview (it begins Wednesday). “If you can’t come up with evidence that proves your case, like a dated, witnessed, and signed lab notebook, you lose. A tie will go to the senior party.” – STAT
AbbVie has launched a collaboration with Boehringer Ingelheim around its late-stage psoriasis drug. AbbVie delivers $595 million in an upfront payment to Boehringer, as well as access to other earlier-stage immunology treatments. – FierceBiotech
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Spark Therapeutics has bought the Irish gene therapy company Genable Technologies for $15 million. Spark will use the Genable’s assets to develop a treatment for the eye disease rhodopsin-linked autosomal dominant retinitis. – FierceDrugDelivery
Valeant shares were rallying on the same day it scheduled a new guidance update for a week from now. – Forbes
Stentys is expanding into Europe. – MassDevice
Argos Therapeutics nabbed $60 million in financing to finance late-stage clinical trials for its immune-based kidney cancer treatment. – Xconomy
FWIW, here’s a company that got $4 million to develop cricket-based protein bars. – PE Hub
PAYERS-PROVIDERS
Get a better look at Ohio-based Mercy Health’s new CEO. – Cincinnati Business Courier
Zika updates:
- HHS is shipping blood and blood products to Puerto Rico because local supplies may be contaminated with Zika.- NBC News
- It looks like additional federal funds to fight Zika won’t leave Congress. – STAT
About 3,500 registered nurses at Sutter Health hospitals won pay increases ranging from 20 percent to 28 percent over four years. – Sacramento Business Journal
We have promising results of the first uterus transplant in the United States. – The New York Times
TECHNOLOGY
MD Anderson rolled out its new Epic EMR build. – Houston Business Journal
Blackrun Ventures has launched a new investment platform that targets businesses for whom women are the end-consumer. Among its first investments: a maternal health technology company. – PR Newswire
POLITICS
There will be no far-reaching probe from Health and Human Services about high drug prices (thanks, Obama). – The Hill
Health Savings Accounts are a big deal in many of the GOP presidential candidates’ Obamacare replacement plans. Now if we could only figure out exactly what those plans are. – Modern Healthcare
A LITTLE BIT EXTRA
I am enjoying my slow plod through my early 40s. But I would also disagree with this assertion: that the late-20s are the worst times of your life. – Harvard Business Review
Photo: Getty Images
